top of page
SHOP
Product
RETATRUTIDE
Retatrutide is an investigational "triple G" peptide targeting three key metabolic receptors: GLP-1, GIP, and Glucagon (GCG).
Details:
Retatrutide is a synthetic peptide that acts as an agonist at three receptors: the GIP receptor, the GLP-1 receptor, and the glucagon receptor (GCGR). It is studied in research on combined incretin and glucagon receptor signalling and metabolic regulation.
Key Benefits:
Unprecedented Total Weight Loss: Clinical trials show average body weight reductions of 24% to over 30% at higher doses (up to 12 mg), approaching bariatric surgery levels and surpassing single- or dual-agonist therapies.
Ideal For:
Individuals looking for weight loss.
bottom of page